Ostarine is definitely the closest SARM to being accepted in medication and it is currently in phase II medical trials. Like SARMs generally, MK-2866 targets androgen receptors on a selective basis and avoids making the kinds of harmful side effects related with substances like testosterone, human growth hormone, or anabolic https://jenningsi432vmd1.illawiki.com/user